In the evolving field of biochemical research, specifi The Telomerase-Derived Anticancer Peptide Vaccine c molecular structures often garner significant attention due to their unique properties. Among these, the GV1001 peptide sequence stands out as a subject of intense scientific inquiry. Often categorized as a synthetic telomerase-specific peptide vaccine, it represents a precise arrangement of building blocks that researchers util GV1001 ize to explore various biological interactions.
Molecular Architecture of GV1001
At its core, GV1001 is a 16-amino-acid peptide. This specific chain is derived from the catalytic site of the human telomerase reverse transcriptase (hTERT) protein, specifically spanning residues 611–626. The structural integrity of this molecule is defined by the following 16-aa hTERT sequence:
H-Glu-Ala-Arg-Pro-Ala-Leu-Leu-Thr-Ser-Arg-Leu-Arg-Phe-Ile-Pro-Lys
This precise amino acid arrangement is what distinguishes the molecule in laboratory settings. Because GV1001 is a 16-amino acid peptide sequence of hTERT protein, it has become a standard reference point for those studying the functional properties of telomerase-derived structures.
Scientific Context and Research Applications
When reviewing literature or laboratory datasets, one will often encounter GV1001 in the context of advanced biochemical studies. It is important to note that GV1001 is a 16-amino-acid peptide that has been extensively documented in academic databases like PubMed and PMC. Beyond its primary classification, GV1001 is a vaccine peptide derived from a 16-amino-acid sequence from the active site of the enzyme, which allows researchers to investigate its potential in various experimental models.
For those interested in the technical nomenclature, the substance is also known as tertomotide. Whether referred to as peptide GV1001 or by its synonym, the molecule consistently displays the same 16-aa human telomerase reverse transcriptase (hTERT) sequence.
Key Characteristics:
* Structure: A linear chain of 16 amino acids.
* Origin: Der hTERT Peptide Fragment GV1001 Prevents the ived from the hTERT protein (residues 611–626).
* Classification: Often investigated as a synthetic telomerase-specific peptide vaccine.
* Synonyms: Known in various by JH Kim·2022·Cited by 20—GV1001, a 16-merpeptidederived from the active site of hTERT, is composed ofamino acidresidues between E611and K626of the hTERT (EARPALLTSRLRFIPK), and Read more research archives as RIAVAX (also known as GV1001) or tertomotide.
Navigating Research Data
When analyzing GV1001 peptide treatment datasets, researchers often focus on the specific sequences involved in protein-protei by JA Kyte·2009·Cited by 126—The present review provides an update on the development of GV1001, a peptide vaccine representing a16-aa hTERT sequence.Read more n interactions. The GV1001; hTERT (611–626) designation is frequently used to ensure accuracy when documenting experimental conditions.
It is noteworthy that GV1001 is a 16-amino acid peptide that exhibits high specificity. In many studies, GV1001, a 16-mer peptide, is utilized to observe how such a small structure can influence biological pathways. Because GV1001 is a 16-amino-acid vaccine peptide, it serves as a foundational tool for those exploring the me Novel vaccine peptide GV1001 effectively blocks β-amyloid chanisms of telomerase inhibition or modulation in non-human, controlled environments.
Conclusion
The study of peptide structures requires a deep understanding of primary Telomerase-specific GV1001 peptide vaccination fails to sequences and their functional implications. As a peptide consisting of 16 amino acids, GV1001 offers a clear, quantifiable subject for biochemical analysis. While many recognize it as GV1001, an anticancer vaccine in its historical context, modern research continues to uncover its diverse roles in experimental biology. By focusing on the precise 16-aa hTERT sequence, scientists can continue to refine their approach to utilizing this unique peptide in various laboratory applications.
*Note: This information is provided for educational and research-related purposes only. GV1001 is a chemical compound intended for laboratory use, not for human consumption or medical treatment.*